Skip to main content
Premium Trial:

Request an Annual Quote

NIH Seeks to Out-License Protein Microarray Technology

NEW YORK (GenomeWeb News) – The National Institutes of Health is seeking to out-license a protein microarray technology currently being developed by researchers at the National Cancer Institute, the NIH said last week.
 
According to the NIH, the technology comprises “a DNA microarray that becomes a protein microarray on demand and provides an efficient systematic approach to the study of protein interactions and drug target identification and validation.
 
"The technology allows a large number of proteins to be synthesized and immobilized at their individual site of expression on an ordered array without the need for protein purification. As a result, proteins are ready for subsequent use in binding studies and other analysis,” the NIH said.
 
Additional details about the technology are available from the NIH’s office of technology transfer.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.